SynAct Pharma AB (SYNACT) — Tangible Net Worth Ratio
SynAct Pharma AB (SYNACT) has a Tangible Net Worth Ratio of 13.2% as of December 2025. This metric is calculated by deducting intangible assets (Skr147.82 Million) from net assets (Skr170.29 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital to net assets of SynAct Pharma AB to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
SynAct Pharma AB Tangible Net Worth Ratio (2014–2025)
This chart shows how SynAct Pharma AB's Tangible Net Worth Ratio has changed across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at 13.2%, reflecting net assets of Skr170.29 Million with intangible assets of Skr147.82 Million SEK. See operational self-sufficiency of SynAct Pharma AB to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for SynAct Pharma AB (2014–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for SynAct Pharma AB from 2014 to 2025, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see SYNACT stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 13.2% | Skr170.29 Million | Skr147.82 Million | Skr220.52 Million | ▼ -14.6 pp |
| 2024 | 27.8% | Skr214.17 Million | Skr154.59 Million | Skr270.52 Million | ▲ +14.2 pp |
| 2023 | 13.6% | Skr176.19 Million | Skr152.16 Million | Skr228.02 Million | ▼ -86.4 pp |
| 2022 | 100.0% | Skr126.52 Million | Skr0.00 | Skr142.60 Million | ▲ +0.0 pp |
| 2021 | 100.0% | Skr20.87 Million | Skr0.00 | Skr38.37 Million | ▲ +0.0 pp |
| 2020 | 100.0% | Skr15.87 Million | Skr0.00 | Skr21.59 Million | ▲ +9.7 pp |
| 2019 | 90.3% | Skr13.50 Million | Skr1.32 Million | Skr23.81 Million | ▼ -2.3 pp |
| 2018 | 92.5% | Skr10.31 Million | Skr769.34K | Skr14.03 Million | ▲ +0.5 pp |
| 2017 | 92.0% | Skr12.91 Million | Skr1.03 Million | Skr15.23 Million | ▼ -4.3 pp |
| 2016 | 96.3% | Skr27.08 Million | Skr992.95K | Skr30.57 Million | ▲ +87.9 pp |
| 2015 | 8.4% | Skr320.00K | Skr293.00K | Skr377.00K | ▼ -30.7 pp |
| 2014 | 39.1% | Skr642.00K | Skr391.00K | Skr723.00K | — |